Matthew D Dallas Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew D Dallas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew D Dallas. Matthew D Dallas is Chief Financial Officer in AVEO PHARMACEUTICALS INC ($AVEO) and VP, Finance in AVEO PHARMACEUTICALS INC ($AVEO) and Chief Financial Officer in CoLucid Pharmaceuticals, Inc. ($CLCD) and Director in Biostage, Inc. ($BSTG).
Latest Insider Trading Transactions of Matthew D Dallas
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, BSTG, CLCD
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 05 2019 | BSTG | Biostage, Inc. | Dallas Matthew D | Director | Option Exercise | A | 2.90 | 8,411 | 24,392 | 18,775 | |
| Jun 05 2019 | BSTG | Biostage, Inc. | Dallas Matthew D | Director | Option Exercise | A | 2.90 | 10,364 | 30,056 | 10,364 | |
| Feb 08 2019 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | A | 0.62 | 450,750 | 279,465 | 450,750 | |
| Nov 15 2018 | BSTG | Biostage, Inc. | Dallas Matthew D | Director | Option Exercise | A | 2.75 | 10,897 | 29,967 | 10,897 | |
| Feb 02 2018 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | A | 3.08 | 250,000 | 770,000 | 250,000 | |
| Jul 05 2017 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | A | 2.22 | 500,000 | 1,110,000 | 500,000 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | D | 6.75 | 37,500 | 253,125 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | D | 7.56 | 30,000 | 226,800 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | D | 10.00 | 180,254 | 1,802,540 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Sell | D | 46.50 | 37,500 | 1,743,750 | 0 | 37.5 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Sell | U | 46.50 | 2,708 | 125,922 | 0 | 2.7 K to 0 (-100.00 %) |
| Jan 04 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Sell | S | 36.25 | 1,473 | 53,396 | 40,128 | 41.6 K to 40.1 K (-3.54 %) |
| Dec 01 2016 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Sell | S | 35.17 | 1,473 | 51,801 | 41,601 | 43.1 K to 41.6 K (-3.42 %) |
| Mar 07 2016 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | A | 6.75 | 37,500 | 253,125 | 37,500 | |
| Mar 07 2016 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Grant | A | 0.00 | 37,500 | 0 | 37,500 | 0 to 37.5 K |
| Aug 06 2015 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | A | 7.56 | 30,000 | 226,800 | 30,000 | |
| May 07 2015 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | A | 10.00 | 180,254 | 1,802,540 | 180,254 | |
| Jan 20 2015 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | VP, Finance | Sell | S | 0.82 | 3,075 | 2,512 | 14,506 | 17.6 K to 14.5 K (-17.49 %) |
| Jan 08 2015 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | VP, Finance | Option Exercise | A | 0.84 | 100,000 | 84,000 | 100,000 | |
| Jan 08 2015 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | VP, Finance | Sell | S | 0.80 | 519 | 415 | 17,581 | 18.1 K to 17.6 K (-2.87 %) |
| Jan 08 2015 | AVEO | AVEO PHARMACEUTICA ... | Dallas Matthew D | VP, Finance | Sell | D | 0.00 | 1,485 | 0 | 18,100 | 19.6 K to 18.1 K (-7.58 %) |
Page: 1